Esperion Therapeutics
ESPR
#6518
Rank
โ‚ฌ0.64 B
Marketcap
2,73ย โ‚ฌ
Share price
-1.70%
Change (1 day)
25.75%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚ฌ0.64 Billion

As of January 2026 Esperion Therapeutics has a market cap of โ‚ฌ0.64 Billion. This makes Esperion Therapeutics the world's 6518th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.64 B-20.53%
2025โ‚ฌ0.81 B88.86%
2024โ‚ฌ0.43 B40.36%
2023โ‚ฌ0.30 B-28.13%
2022โ‚ฌ0.42 B59.16%
2021โ‚ฌ0.26 B-50.92%
2020โ‚ฌ0.54 B-62.57%
2019โ‚ฌ1.46 B35.7%
2018โ‚ฌ1.07 B-24.97%
2017โ‚ฌ1.43 B435.49%
2016โ‚ฌ0.26 B-41.44%
2015โ‚ฌ0.45 B-32.23%
2014โ‚ฌ0.67 B343.19%
2013โ‚ฌ0.15 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Esperion Therapeutics was reported to be:

โ‚ฌ0.66 Billion
by Nasdaq info icon info icon
โ‚ฌ0.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.97 B 204.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ9.13 B 1,309.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ126.49 B 19,422.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ67.83 B 10,370.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ3.81 B 489.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚ฌ0.39 B-38.88%๐Ÿ‡บ๐Ÿ‡ธ USA